Impact of First-Line vs Second-Line Antibiotics for the Treatment of Acute Uncomplicated Sinusitis

CONTEXT Studies suggest little benefit in relief of acute sinusitis symptoms from the use of newer and more expensive (second-line) antibiotics instead of older and less expensive (first-line) antibiotics. However, researchers have failed to include development of complications and cost of care in t...

Full description

Saved in:

Bibliographic Details
Published in:	JAMA : the journal of the American Medical Association Vol. 286; no. 15; pp. 1849 - 1856
Main Authors:	Piccirillo, Jay F, Mager, Douglas E, Frisse, Mark E, Brophy, Robert H, Goggin, Andrew
Format:	Journal Article
Language:	English
Published:	Chicago, IL American Medical Association 17-10-2001
Subjects:	Acute Disease Adult Analysis of Variance Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - economics Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cost-Benefit Analysis Drug therapy Drug Utilization Female Humans Logistic Models Male Medical disorders Medical sciences Outcome Assessment (Health Care) Pharmacology. Drug treatments Retrospective Studies Sinusitis - classification Sinusitis - drug therapy Sinusitis - economics Treatment Outcome United States United States Human Prognosis Acute Sinusitis Antibiotic Chemotherapy Treatment Health economy ENT disease Paranasal sinus disease Antibacterial agent Public health Cost efficiency analysis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	CONTEXT Studies suggest little benefit in relief of acute sinusitis symptoms from the use of newer and more expensive (second-line) antibiotics instead of older and less expensive (first-line) antibiotics. However, researchers have failed to include development of complications and cost of care in their analyses. OBJECTIVE To compare the effectiveness and cost of first-line with second-line antibiotics for the treatment of acute uncomplicated sinusitis in adults. DESIGN, SETTING, AND PATIENTS Retrospective cohort study using a pharmaceutical database containing demographic, clinical (International Classification of Diseases, Ninth Revision), treatment, and charge information for 29 102 adults with a diagnosis of acute sinusitis receiving initial antibiotic treatment between July 1, 1996, and June 30, 1997. MAIN OUTCOME MEASURES Absence of additional claim for an antibiotic in the 28 days after the initial antibiotic, presence of a claim for a second antibiotic, serious complications of sinusitis, and direct charges and use for the acute sinusitis treatment. RESULTS There were 17 different antibiotics prescribed in this study. The majority (59.5%) of patients received 1 of the first-line antibiotics. The overall success rate was 90.4% (95% confidence interval [CI], 90.0%-90.8%). The success rate for the 17 329 patients who received a first-line antibiotic was 90.1% and for the 11 773 patients who received a second-line antibiotic was 90.8%, a difference of 0.7% (95% CI, 0.01%-1.40%; P<.05). There were 2 cases of periorbital cellulitis, one in each treatment group. The average total direct charge for patients receiving a first-line antibiotic was $68.98 and a second-line antibiotic was $135.17, a difference of $66.19 (95% CI, $64.95-$67.43; P<.001). This difference was due entirely to the difference in charge of antibiotics and not other charges, such as professional fees, laboratory tests, or emergency department visits. CONCLUSIONS Patients treated with a first-line antibiotic for acute uncomplicated sinusitis did not have clinically significant differences in outcomes vs those treated with a second-line antibiotic. However, cost of care was significantly higher for patients treated with a second-line antibiotic.
ISSN:	0098-7484 1538-3598
DOI:	10.1001/jama.286.15.1849